Search Results - "O'Gorman, Tessa"
-
1
HepCare Plus: Enhancing Primary Care Identification and Treatment of Hepatitis C Virus in High-Risk Individuals
Published in Pathogens (Basel) (27-11-2022)“…Hepatitis C Virus (HCV) disproportionately affects people who inject drugs, migrants, prisoners and the homeless. An integrated, peer-led model of care…”
Get full text
Journal Article -
2
Hepatitis C community prevalence is over-estimated: a prospective, birth cohort study
Published in Irish journal of medical science (01-06-2024)“…Background Hepatitis C virus infection is often asymptomatic, and many patients may be unaware they are infected. Community-based, birth cohort screening has…”
Get full text
Journal Article -
3
Impact of vaccination and variants of concern on long COVID clinical phenotypes
Published in BMC infectious diseases (16-11-2023)“…Abstract Background Defining patterns of symptoms in long COVID is necessary to advance therapies for this heterogeneous condition. Here we aimed to describe…”
Get full text
Journal Article -
4
Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection
Published in Frontiers in immunology (17-09-2024)“…A clear immune correlate of protection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has not been defined. We explored antibody,…”
Get full text
Journal Article -
5
2338. Robust and Persistent B Cell Responses Following Third Dose SARS-CoV-2 Vaccine Determine Protection from COVID-19
Published in Open forum infectious diseases (27-11-2023)“…Abstract Background The immunological memory to SARS-CoV-2 (SCV-2) vaccination has multiple components, with robust antibody (Ab) and B cell responses…”
Get full text
Journal Article -
6
1959. Lower B-Cell Responses Rather Than Circulating Antibody Titres Are Associated With SARS-CoV-2 Infection Post Third Dose COVID-19 Vaccination
Published in Open forum infectious diseases (15-12-2022)“…Abstract Background Which components of the immune response to SARS-CoV-2 vaccination best protect against subsequent infection remains unclear. We explored…”
Get full text
Journal Article